1. Home
  2. EFC vs NVCR Comparison

EFC vs NVCR Comparison

Compare EFC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EFC

Ellington Financial Inc.

HOLD

Current Price

$11.75

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Logo NovoCure Limited

NVCR

NovoCure Limited

HOLD

Current Price

$12.05

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EFC
NVCR
Founded
2007
2000
Country
United States
Switzerland
Employees
400
N/A
Industry
Real Estate
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
EFC
NVCR
Price
$11.75
$12.05
Analyst Decision
Strong Buy
Buy
Analyst Count
5
6
Target Price
$14.55
$28.08
AVG Volume (30 Days)
1.6M
1.7M
Earning Date
01-01-0001
05-20-2026
Dividend Yield
13.01%
N/A
EPS Growth
N/A
21.79
EPS
N/A
N/A
Revenue
N/A
$655,353,000.00
Revenue This Year
N/A
$7.72
Revenue Next Year
$52.40
$6.74
P/E Ratio
$9.50
N/A
Revenue Growth
N/A
8.28
52 Week Low
$11.12
$9.82
52 Week High
$14.12
$20.05

Technical Indicators

Market Signals
Indicator
EFC
NVCR
Relative Strength Index (RSI) 30.06 46.18
Support Level $11.57 $10.86
Resistance Level $14.00 $13.78
Average True Range (ATR) 0.26 0.70
MACD 0.00 -0.11
Stochastic Oscillator 17.50 10.04

Price Performance

Historical Comparison
EFC
NVCR

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

Share on Social Networks: